Risk of bradycardia and syncope associated with the use of cholinesterase inhibitors in patients with Alzheimer disease and related dementias: A systematic review and meta-analysis
Authors:
- Chijioke M. OkekeCOChijioke M. Okeke
- Tenia SladeTSTenia Slade
- Sarah Beth TuckerSTSarah Beth Tucker
- Olivia WhitworthOWOlivia Whitworth
- Amey RaneARAmey Rane
- Bryan L. LoveBLBryan L. Love
- Ibraheem M. KarayeIKIbraheem M. Karaye
- Saud AlsahaliSASaud Alsahali
- Nasim MalekiNMNasim Maleki
- Nawaf M. AlotaibiNANawaf M. Alotaibi
- J. Douglas ThorntonJTJ. Douglas Thornton
- Karen McGeeKMKaren McGee
Open Access
- 18 January 2026
- journal article
- review article
- Published by Elsevier in JAPhA Pharmacotherapy
- Vol. 3 (2)
Abstract
No abstract availableThis publication has 56 references indexed in Scilit:
- Alzheimer Disease Treatment With Acetylcholinesterase Inhibitors and Incident Age-Related Macular DegenerationJAMA Ophthalmology, 2024
- Association of Antidementia Therapies With Time to Skilled Nursing Facility Admission and Cardiovascular Events Among Elderly Adults With Alzheimer DiseaseJAMA Network Open, 2019
- Measuring the statistical validity of summary meta‐analysis and meta‐regression results for use in clinical practiceStatistics in Medicine, 2017
- Reporting of Safety Results in Published Reports of Randomized Controlled TrialsArchives of internal medicine (1960), 2009
- Syncope and Its Consequences in Patients With Dementia Receiving Cholinesterase InhibitorsArchives of internal medicine (1960), 2009
- Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patientsMovement Disorders, 2008
- Efficacy and safety of donepezil over 3 years: an open‐label, multicentre study in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2007
- A Prescribing Cascade Involving Cholinesterase Inhibitors and Anticholinergic DrugsArchives of internal medicine (1960), 2005
- Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2001
- Donepezil Improves Cognition and Global Function in Alzheimer DiseaseA 15-Week, Double-blind, Placebo-Controlled StudyArchives of internal medicine (1960), 1998